Aspire Biopharma Holdings, Inc.
ASBPNASDAQHealthcare● Active
$6.65
+$1.31(+24.53%)
Market Cap$767224
P/E Ratio—
52W High$35
52W Low$0.11
Aspire Biopharma Holdings, Inc. (ASBP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASBP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($0.00M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -1.87% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.92M | $0.14M | $0.07M | $0.18M | $0.00M |
| G&A Expenses | $17.64M | $3.09M | $1.34M | $0.98M | $0.03M |
| Total Operating Expenses | $19.35M | $3.09M | $1.34M | $0.98M | $0.03M |
| Operating Income | ($19.35M) | ($3.09M) | ($1.34M) | ($0.98M) | ($0.03M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.55M | $5.81M | $4.32M | $0.00M |
| Interest Expense | $8.53M | ($0.89M) | $0.01M | $0.00M | $0.00M |
| Income Before Tax | ($24.48M) | ($12.54M) | $4.46M | $3.34M | ($0.03M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($24.48M) | ($12.54M) | $4.46M | $3.34M | ($0.03M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-16.38 | $-18.17 | $9.31 | $3.72 | $-0.04 |
| Wtd Avg Shares | 1.49M | 0.69M | 0.48M | 0.90M | 0.68M |
| EBITDA | ($19.35M) | ($11.65M) | $5.80M | $3.34M | ($0.03M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Aspire Biopharma Holdings, Inc. data
About Aspire Biopharma Holdings, Inc. (ASBP) Income Statement
Aspire Biopharma Holdings, Inc. (ASBP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ASBP reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -1.87%), and net income of ($0.02B) — a net profit margin of -394725.06%.
Frequently asked questions
ASBP · 4 questionsAspire Biopharma Holdings, Inc. (ASBP) reported revenue of $0.00B for 2025, up —% year-over-year.
ASBP revenueASBP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09